About the Journal

Journal of Innovation in Computer Science and Pharma-Bio Research

 

The Journal of Innovation in Computer Science and Pharma-Bio Research is an academic platform for the dissemination of research and scientific developments in computer science, pharmaceutical sciences, biotechnology, and biomedical research.

 

The journal provides opportunities for researchers, academicians, scientists, pharmaceutical professionals, biotechnologists, and information technology specialists to share original research, review articles, and innovative findings that contribute to advancements in computing technologies, pharmaceutical development, biological sciences, and interdisciplinary research.

 

Subject Area

 

The journal’s subject areas fall under the broad domains of Computer Science, Pharmaceutical Sciences, Biotechnology, and Biomedical Research, covering a range of topics, including but not limited to:

 

Computer Science and Information Technology

Artificial Intelligence and Machine Learning

Data Science and Computational Methods

Software Engineering and Computer Applications

Pharmaceutical Chemistry

Pharmaceutics and Drug Delivery Systems

Pharmacology and Toxicology

Pharmacognosy and Natural Products Research

Pharmaceutical Analysis and Quality Assurance

Biotechnology and Molecular Biology

Microbiology and Biochemistry

Bioinformatics and Computational Biology

Computer-Aided Drug Design and Drug Discovery

Biomedical Research and Healthcare Technologies

Computational Biology and Molecular Modeling

Medical Informatics and Digital Healthcare

Interdisciplinary Research in Computer Science and Pharma-Bio Sciences

Emerging Technologies in Pharmaceutical and Biological Research

Aim and Scope

 

Aim: To encourage scientific innovation and promote high-quality research in computer science, pharmaceutical sciences, biotechnology, and biomedical research, with particular emphasis on interdisciplinary collaboration and the application of emerging technologies to pharmaceutical and biological sciences.

 

Scope: The journal welcomes original research articles, review papers, and other scholarly contributions addressing advances in computer science, pharmaceutical sciences, biotechnology, and related biomedical fields. Relevant topics include artificial intelligence applications, computational drug discovery, pharmaceutical formulation, drug delivery, bioinformatics, molecular modeling, biological data analysis, and innovative technologies supporting healthcare and life sciences.

 

Publication Model

Peer Review: Double-blind peer review. See the Peer Review Process page for details.

Access Model: Open Access. All published articles are freely and permanently available to readers without subscription or access fees.

License: Creative Commons Attribution 4.0 International (CC BY 4.0)

Article Processing Charges: None. The journal does not charge submission, processing, or publication fees.

Publication Frequency: [to be added, e.g., Quarterly / Biannual / Continuous]

Article Types: Original Research Articles, Review Articles, Short Communications, Case Studies / Applied Research Reports, and Conceptual or Methodological Papers. See the Author Guidelines for details.

Ethical Standards

 

The journal is committed to publication ethics that promote academic integrity, research transparency, and responsible scholarly communication, in line with the principles of the Committee on Publication Ethics (COPE).

 

Authors are expected to ensure the originality of their submissions, proper acknowledgment of sources, accurate reporting of results, disclosure of relevant conflicts of interest, and compliance with applicable ethical requirements for research involving human participants, animals, or biological materials.

 

Editorial decisions and peer-review procedures follow recognized publication ethics standards and the journal’s Publication Ethics, Plagiarism, and Peer Review policies.

 

Publisher Information

Publisher: [to be added]

Country of Publication: [to be added]

ISSN: [to be added / “Applied for” if pending]

Communication

 

Editorial correspondence, manuscript submissions, and inquiries regarding publication policies should be directed to the journal’s official email: [journal email to be added]